chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Urticaria
Clinical narrative: Case number PHHY2016US090708, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20 Jun 2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, Typhoid vaccine, Td/Tdap vaccine, Yellow fever vaccine and Anthrax vaccine absorbed without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient experienced same thing occurring in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17 Mar 2004 and Influenza vaccine on an unknown date in Oct 2006 (Med immune 500433P) and experienced progressive site irritation (small erythematous area at site). The patient also vaccinated with Flu mist on 22 Nov 2008 and 28 Aug 2009 with no adverse reaction. The patient vaccinated with H1N1 influenza vaccine (batch number: not reported) on 25 Nov 2009 and experienced progressive site irritation (small erythematous area at site that would progress each year). The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 25 Sep 2010. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). It was stated that, allergist note on 18 Apr 2012, listed possible hepatitis B non-responder with negative varicella IgG, and positive MMR titers from 2009. The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following internal review done on 05 Jul 2016 for the data received on 20 Jun 2016: Following changes were done. Events Hepatitis, Measles virus test positive, Mumps virus test positive and Rubella virus test positive were deleted from the event tab as these events were not experienced by the patient.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Injection site erythema, Injection site irritation
Clinical narrative: Case number PHHY2016US090708, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20 Jun 2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, Typhoid vaccine, Td/Tdap vaccine, Yellow fever vaccine and Anthrax vaccine absorbed without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient experienced same thing occurring in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17 Mar 2004 and Influenza vaccine on an unknown date in Oct 2006 (Med immune 500433P) and experienced progressive site irritation (small erythematous area at site). The patient also vaccinated with Flu mist on 22 Nov 2008 and 28 Aug 2009 with no adverse reaction. The patient vaccinated with H1N1 influenza vaccine (batch number: not reported) on 25 Nov 2009 and experienced progressive site irritation (small erythematous area at site that would progress each year). The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 25 Sep 2010. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). It was stated that, allergist note on 18 Apr 2012, listed possible hepatitis B non-responder with negative varicella IgG, and positive MMR titers from 2009. The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following internal review done on 05 Jul 2016 for the data received on 20 Jun 2016: Following changes were done. Events Hepatitis, Measles virus test positive, Mumps virus test positive and Rubella virus test positive were deleted from the event tab as these events were not experienced by the patient.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Erythema, Hepatitis B antibody positive, Injection site erythema, Injection site irritation, Measles antibody positive
Clinical narrative: Case number PHHY2016US090708, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20 Jun 2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, Typhoid vaccine, Td/Tdap vaccine, Yellow fever vaccine and Anthrax vaccine absorbed without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient experienced same thing occurring in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17 Mar 2004 and Influenza vaccine on an unknown date in Oct 2006 (Med immune 500433P) and experienced progressive site irritation (small erythematous area at site). The patient also vaccinated with Flu mist on 22 Nov 2008 and 28 Aug 2009 with no adverse reaction. The patient vaccinated with H1N1 influenza vaccine (batch number: not reported) on 25 Nov 2009 and experienced progressive site irritation (small erythematous area at site that would progress each year). The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 25 Sep 2010. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). It was stated that, allergist note on 18 Apr 2012, listed possible hepatitis B non-responder with negative varicella IgG, and positive MMR titers from 2009. The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following internal review done on 05 Jul 2016 for the data received on 20 Jun 2016: Following changes were done. Events Hepatitis, Measles virus test positive, Mumps virus test positive and Rubella virus test positive were deleted from the event tab as these events were not experienced by the patient.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Morbillivirus test positive, Mumps antibody test positive, Peripheral swelling, Rubella antibody positive, Rubivirus test positive
Clinical narrative: Case number PHHY2016US090708, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20 Jun 2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, Typhoid vaccine, Td/Tdap vaccine, Yellow fever vaccine and Anthrax vaccine absorbed without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient experienced same thing occurring in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17 Mar 2004 and Influenza vaccine on an unknown date in Oct 2006 (Med immune 500433P) and experienced progressive site irritation (small erythematous area at site). The patient also vaccinated with Flu mist on 22 Nov 2008 and 28 Aug 2009 with no adverse reaction. The patient vaccinated with H1N1 influenza vaccine (batch number: not reported) on 25 Nov 2009 and experienced progressive site irritation (small erythematous area at site that would progress each year). The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 25 Sep 2010. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). It was stated that, allergist note on 18 Apr 2012, listed possible hepatitis B non-responder with negative varicella IgG, and positive MMR titers from 2009. The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following internal review done on 05 Jul 2016 for the data received on 20 Jun 2016: Following changes were done. Events Hepatitis, Measles virus test positive, Mumps virus test positive and Rubella virus test positive were deleted from the event tab as these events were not experienced by the patient.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Rubulavirus test positive
Clinical narrative: Case number PHHY2016US090708, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20 Jun 2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, Typhoid vaccine, Td/Tdap vaccine, Yellow fever vaccine and Anthrax vaccine absorbed without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient experienced same thing occurring in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17 Mar 2004 and Influenza vaccine on an unknown date in Oct 2006 (Med immune 500433P) and experienced progressive site irritation (small erythematous area at site). The patient also vaccinated with Flu mist on 22 Nov 2008 and 28 Aug 2009 with no adverse reaction. The patient vaccinated with H1N1 influenza vaccine (batch number: not reported) on 25 Nov 2009 and experienced progressive site irritation (small erythematous area at site that would progress each year). The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 25 Sep 2010. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). It was stated that, allergist note on 18 Apr 2012, listed possible hepatitis B non-responder with negative varicella IgG, and positive MMR titers from 2009. The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following internal review done on 05 Jul 2016 for the data received on 20 Jun 2016: Following changes were done. Events Hepatitis, Measles virus test positive, Mumps virus test positive and Rubella virus test positive were deleted from the event tab as these events were not experienced by the patient.
Age: 79.0
Sex: M
Vaccine: FLUX, PNC13, PNC13, FLUX, PNC13
Symptoms: Biopsy prostate, Blood cholesterol, Blood pressure increased, Blood triglycerides
Clinical narrative: Case number PHHY2016US088760, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 633585) website on 20 Jun 2016. This report refers to a 79 years old male patient. Past medical history was not reported. Current condition included thyroid disorder (reported as for about 10 years). Concomitant medications included levothyroxine 0.05mg one daily in the morning for thyroid. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) (reported as on the top on arm) along with first dose of PREVENAR 13 vaccine (other manufacturer and batch number: not reported), both in left arm on 05 Oct 2015. On an unknown date, the patient experienced increased blood pressure prior to the second dose of PREVENAR 13. The patient was treated atenolol for high blood pressure. The patient was vaccinated with second dose of PREVENAR 13 (other manufacturer and batch number: not reported) in the top of right arm on an unknown date in Nov 2015 at 8:00 PM (IST). It was reported that, the blood pressure of patient was good at the time of vaccination. Laboratory test included cholesterol testing, prostatic biopsy testing, and triglycerides (results, units and normal ranges not reported). The outcome of the event was not reported. Final outcome of the event was unknown. The seriousness of the event was reported as non serious by the consumer. The causality of the event was not reported.
Age: 79.0
Sex: M
Vaccine: FLUX, PNC13, PNC13, FLUX, PNC13
Symptoms: Blood pressure increased
Clinical narrative: Case number PHHY2016US088760, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 633585) website on 20 Jun 2016. This report refers to a 79 years old male patient. Past medical history was not reported. Current condition included thyroid disorder (reported as for about 10 years). Concomitant medications included levothyroxine 0.05mg one daily in the morning for thyroid. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) (reported as on the top on arm) along with first dose of PREVENAR 13 vaccine (other manufacturer and batch number: not reported), both in left arm on 05 Oct 2015. On an unknown date, the patient experienced increased blood pressure prior to the second dose of PREVENAR 13. The patient was treated atenolol for high blood pressure. The patient was vaccinated with second dose of PREVENAR 13 (other manufacturer and batch number: not reported) in the top of right arm on an unknown date in Nov 2015 at 8:00 PM (IST). It was reported that, the blood pressure of patient was good at the time of vaccination. Laboratory test included cholesterol testing, prostatic biopsy testing, and triglycerides (results, units and normal ranges not reported). The outcome of the event was not reported. Final outcome of the event was unknown. The seriousness of the event was reported as non serious by the consumer. The causality of the event was not reported.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Injection site pain
Clinical narrative: Case number PHHY2016US088850, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 633969) website on 20 Jun 2016. This report refers to a 40 years old female patient. Past medical history was not reported. Current conditions included type 2 diabetes. Concomitant medications metformin (manufacturer unknown). The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) in arm on 02 Feb 2016. On 03 Feb 2016, the patient experienced very sore arm at injection site. The arm was sore even months later. The outcome of the event was not reported (missing). The seriousness of the event was reported as non serious. The causality of the event was not reported.
Sex: U
Vaccine: FLUX, FLUX
Symptoms: Musculoskeletal pain
Clinical narrative: Case number PHHY2016US088788, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 634056) website on 20 Jun 2016. This report refers to a 71 year old patient of an unknown gender. Medical history and concomitant medication were not reported. The patient received was vaccinated with Seasonal Influenza Virus Vaccine Inn (manufacturer unknown, batch number: not reported) in his left shoulder in Oct 2015. After vaccination an unspecified date in Oct 2015, the patient experienced shoulder pain. The outcome of the event was condition unchanged. Seriousness of the event was reported as non serious and causality of the event musculoskeletal pain were not reported.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Injection site pain
Clinical narrative: Case number PHHY2016US088653 is an initial spontaneous report received from consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 634195) on 20 Jun 2016. This report refers to a female patient of an unknown age. Medical history and concomitant medication were not reported. The patient was vaccinated with Seasonal Influenza vaccine, (manufacturer: unknown, batch number: not reported) on an unknown date.  On an unspecified date, at the time of vaccination, the patient was hurt and could feel the needle went in. The laboratory investigations and corrective treatment were not reported. The outcome, seriousness and causality of event were not reported.
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site erythema, Injection site pruritus, Injection site scab, Pain, Pain in extremity
Clinical narrative: Case number PHHY2016US090349, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 634234) website on 20 Jun 2016. This report refers to an 81 years old female patient. Past medical history was not reported. Past vaccination history included vaccination several times with Flu vaccine (manufacturer unknown) on unspecified dates. Current conditions included increased blood pressure and diabetes. Concomitant medications were not reported. The patient was vaccinated with FLUZONE (other manufacturer, batch number: U5016BA, expiry date: not reported) intramuscularly in the left deltoid in Oct 2014. The patient was also vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) on an unknown date after receiving FLUZONE vaccine. Post vaccination, the patient experienced red area at injection site of left arm and itches at injection site, repeated scab over, also stated that the scabs came off and experienced shooting type pain in her left arm. The patient visited the emergency room. The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious by the consumer. The causality of the events was not reported.
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site erythema, Injection site pruritus, Injection site scab, Pain in extremity
Clinical narrative: Case number PHHY2016US090349, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 634234) website on 20 Jun 2016. This report refers to an 81 years old female patient. Past medical history was not reported. Past vaccination history included vaccination several times with Flu vaccine (manufacturer unknown) on unspecified dates. Current conditions included increased blood pressure and diabetes. Concomitant medications were not reported. The patient was vaccinated with FLUZONE (other manufacturer, batch number: U5016BA, expiry date: not reported) intramuscularly in the left deltoid in Oct 2014. The patient was also vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) on an unknown date after receiving FLUZONE vaccine. Post vaccination, the patient experienced red area at injection site of left arm and itches at injection site, repeated scab over, also stated that the scabs came off and experienced shooting type pain in her left arm. The patient visited the emergency room. The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious by the consumer. The causality of the events was not reported.
Age: 64.0
Sex: M
Vaccine: FLU3, FLUX
Symptoms: Influenza, Malaise, Nasal congestion
Clinical narrative: Case number PHHY2016US090415, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 634235) website on 20 Jun 2016. This report refers to a 64 years old male patient. Past medical history was not reported. Concomitant medications included VENTOLIN HFA. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) in Nov 2015 (as while he was on VENTOLIN HFA). On an unknown date after vaccination, the patient reported being sick and experienced nasal congestion/ congestion during sickness. It was also reported that, patient experienced sickness or flu about 2 weeks after receiving the Flu vaccine. The patient attributed this flu vaccine to a lack of effect or coverage of the 2015/2016 influenza shot he received. The outcome of the events was unknown. The seriousness of the events was reported as non serious by the consumer. The causality of the events was not reported. The seriousness of the events influenza, nasal congestion and malaise and vaccine failure was upgraded to medically significant based on the information available in the source document.
Age: 64.0
Sex: M
Vaccine: FLU3, FLUX
Symptoms: Drug ineffective, Influenza, Malaise, Nasal congestion, Vaccination failure
Clinical narrative: Case number PHHY2016US090415, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 634235) website on 20 Jun 2016. This report refers to a 64 years old male patient. Past medical history was not reported. Concomitant medications included VENTOLIN HFA. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) in Nov 2015 (as while he was on VENTOLIN HFA). On an unknown date after vaccination, the patient reported being sick and experienced nasal congestion/ congestion during sickness. It was also reported that, patient experienced sickness or flu about 2 weeks after receiving the Flu vaccine. The patient attributed this flu vaccine to a lack of effect or coverage of the 2015/2016 influenza shot he received. The outcome of the events was unknown. The seriousness of the events was reported as non serious by the consumer. The causality of the events was not reported. The seriousness of the events influenza, nasal congestion and malaise and vaccine failure was upgraded to medically significant based on the information available in the source document.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Injection site joint pain, Injection site pain, Injection site warmth, Weight bearing difficulty
Clinical narrative: Case number PHHY2016US089179 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS  reference number: 634775) website on 20 Jun 2016. This report refers to a 57 year female patient. Past medical history included depression and low potassium; current condition included high cholesterol and hypothyroidism. No concomitant medications were reported. The patient was vaccinated with Seasonal Influenza vaccine, (manufacturer: unknown, batch number: not reported) intramuscularly into left arm on 04 Feb 2016. On 05 Feb 2016, the patient had muscle ache at injection site (upper left arm near shoulder) soreness continues and now she had pain in joint area. Her pain was getting progressively worse and upper shoulder area felt warm to the touch. She could not lift 3lb weight. The outcome of the events was reported as condition unchanged. The seriousness of the events reported as non serious. The causality of events were not reported.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Arthralgia, Injection site pain, Muscular weakness, Skin warm
Clinical narrative: Case number PHHY2016US089179 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS  reference number: 634775) website on 20 Jun 2016. This report refers to a 57 year female patient. Past medical history included depression and low potassium; current condition included high cholesterol and hypothyroidism. No concomitant medications were reported. The patient was vaccinated with Seasonal Influenza vaccine, (manufacturer: unknown, batch number: not reported) intramuscularly into left arm on 04 Feb 2016. On 05 Feb 2016, the patient had muscle ache at injection site (upper left arm near shoulder) soreness continues and now she had pain in joint area. Her pain was getting progressively worse and upper shoulder area felt warm to the touch. She could not lift 3lb weight. The outcome of the events was reported as condition unchanged. The seriousness of the events reported as non serious. The causality of events were not reported.
Sex: F
Vaccine: FLUX
Symptoms: Allergy to vaccine
Clinical narrative: Case number PHHY2016US089245 is an initial spontaneous report received from other health professional via Vaccine Adverse Event Reporting System (VAERS reference number: 635055) on 20 Jun 2016. This report refers to a female patient of an unknown age. Medical history and concomitant medications were not reported. The patient was vaccinated with Seasonal Influenza vaccine, (manufacturer: unknown, batch number: not reported) on an unknown date. On an unspecified date, after vaccination the patient experienced allergy to vaccine. The laboratory investigations was not reported. Outcome and causality of event were not reported. The seriousness of the event was reported as non serious.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Injection site reaction, Local reaction, Malaise
Clinical narrative: Case number PHHY2016US088873, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 635428) website on 20 Jun 2106. This report refers to a female patient of unknown age. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported_ on an unknown date (reported as last year). On an unknown date following the vaccination, the patient experienced local reaction at the site of injection and got sick. It was reported that, the doctor believed it was due to a preservative in the multi dose vial of the flu vaccine. The outcome of the events was reported as unknown. The seriousness of the events was reported and non serious by the consumer. The causality of the vents was not reported.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Allergy to vaccine
Clinical narrative: Case number PHHY2016US089260 is an initial spontaneous report received from physician via other company via Vaccine Adverse Event Reporting System (VAERS reference number: 635431) on  20 Jun 2016. this report refers to 65 year old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with Seasonal Influenza vaccine, (manufacturer: unknown, batch number: not reported) on an unknown date. On an unspecified date, following the vaccination, the patient developed allergy to flu vaccine. The lab data and corrective treatment were not reported. The outcome and causality of event were not reported. The seriousness of the event was reported as non serious.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Allergy to vaccine
Clinical narrative: Case number PHHY2016US088807, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 635477) website on 20 Jun 2016. This report refers to an unknown age of female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. On an unspecified date, following the vaccination, the patient had developed allergy to influenza vaccines. The outcome of the event was reported as unknown. The seriousness of the event was reported as non serious. The causality of the event was not reported.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Hypersensitivity
Clinical narrative: Case number PHHY2016US088807, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 635477) website on 20 Jun 2016. This report refers to an unknown age of female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. On an unspecified date, following the vaccination, the patient had developed allergy to influenza vaccines. The outcome of the event was reported as unknown. The seriousness of the event was reported as non serious. The causality of the event was not reported.
Age: 30.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Incorrect route of drug administration, Injection site reaction, Injection site swelling, Urticaria, Wrong drug administered
Clinical narrative: Case number PHHY2016US107125 is an initial spontaneous report received from an other healthcare professional via Vaccine Adverse Event Reporting System (VAERS reference number: 635774) on 01 Aug 2016. This report refers to a 30 years old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine, (manufacturer: unknown, batch number: not reported) on an unknown date. On an unspecified date, the patient had received influenza vaccine in hand (poked it) instead of TUBERSOL. After some hour, patient was informed that they had somehow mixed up the vials throughout the day and the nurse had injected influenza instead of TB under patient skin. It was reported that patient had taken TB tests before but stated that experience with her nurse on the day of vaccination was unusual. On an unspecified date, after vaccination the patient experienced injection site swelling which began to welt up and urticaria. It was a case of wrong vaccine administered and wrong route of administration. Lab tests and corrective treatments were not reported. The seriousness of the events was non serious. The outcome and causality of events was not reported. Seriousness of the event urticaria was upgraded based on the information available in the source document.
Age: 30.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Incorrect route of drug administration, Injection site swelling, Injection site urticaria, Wrong drug administered
Clinical narrative: Case number PHHY2016US107125 is an initial spontaneous report received from an other healthcare professional via Vaccine Adverse Event Reporting System (VAERS reference number: 635774) on 01 Aug 2016. This report refers to a 30 years old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine, (manufacturer: unknown, batch number: not reported) on an unknown date. On an unspecified date, the patient had received influenza vaccine in hand (poked it) instead of TUBERSOL. After some hour, patient was informed that they had somehow mixed up the vials throughout the day and the nurse had injected influenza instead of TB under patient skin. It was reported that patient had taken TB tests before but stated that experience with her nurse on the day of vaccination was unusual. On an unspecified date, after vaccination the patient experienced injection site swelling which began to welt up and urticaria. It was a case of wrong vaccine administered and wrong route of administration. Lab tests and corrective treatments were not reported. The seriousness of the events was non serious. The outcome and causality of events was not reported. Seriousness of the event urticaria was upgraded based on the information available in the source document.
Sex: F
Vaccine: FLUX, PPV, FLUX, PPV
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Case number PHHY2016US105034 is an initial spontaneous report received from healthcare professional via Vaccine Adverse Event Reporting System (VAERS reference number: 635878) on 01 Aug 2016. This report refers to a 66-year-old female patient. Medical history and concomitant medication was not reported. The patient received Seasonal Influenza Virus vaccine and pneumococcal vaccine into arm on an unknown date. The patient arm was very sore where shots were given, the patient could not raise arm, could not reach arm around back. The patient was treated with physical therapy. The outcome of the event was condition unchanged. Seriousness of the event was reported as non serious and causality was not reported.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Back pain, Injection site pain, Muscle spasms, Musculoskeletal pain
Clinical narrative: Case number PHHY2016US105687, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 636270) on 01 Aug 2016. This report refers to a 72 years old female patient. Past medical history was not reported. Current condition included stage 3 kidney disease. Concomitant medications included MULTAQ, Aspirin and ELAVIL. She was vaccinated with seasonal influenza vaccine (unknown manufacturer, batch number: not reported) into the left arm on 02 Nov 2015. After vaccination, on 03 Nov 2015, she experienced pain in back, shoulder and upper left arm and muscle spasms of rhomboid muscle. She visited chiropractor 2 times but there was no relief, received muscle relaxer from general practitioner, but it did not help. She also got 2 massages which led to no relief and received steroids which did not last. She was prescribed with physiotherapy. Final outcome of the events was reported as condition unchanged. The events were assessed as non serious and causality was not reported.
Sex: F
Vaccine: FLUX, PPV, FLUX, PPV
Symptoms: Crying, Injection site pain, Malaise, Mobility decreased, Pain
Clinical narrative: Case number PHHY2016US107364, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 636460) website on 01 Aug 2016. This report refers to a 52 years old female patient. Past medical history was not reported. Concomitant medications included LEXAPRO (escitalopram oxalate) 10 mg. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) along with Pneumococcal vaccine (manufacturer unknown and batch number: not reported) both in right arm on 19 Oct 2015. On the same day after vaccination, the vaccination site became extremely painful. The patient could not lift arm and had trouble starting her car as the arm hurt. The patient drove the car crying uncontrollably due to pain. Once home, the patient was taken into the emergency room due to extreme pain and ill feeling. Her arm and shoulder did not healed properly. The patient reported that she experience pain daily. The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, PPV, FLUX, PPV
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2016US107364, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 636460) website on 01 Aug 2016. This report refers to a 52 years old female patient. Past medical history was not reported. Concomitant medications included LEXAPRO (escitalopram oxalate) 10 mg. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) along with Pneumococcal vaccine (manufacturer unknown and batch number: not reported) both in right arm on 19 Oct 2015. On the same day after vaccination, the vaccination site became extremely painful. The patient could not lift arm and had trouble starting her car as the arm hurt. The patient drove the car crying uncontrollably due to pain. Once home, the patient was taken into the emergency room due to extreme pain and ill feeling. Her arm and shoulder did not healed properly. The patient reported that she experience pain daily. The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, PPV, FLUX, PPV
Symptoms: Crying, Injected limb mobility decreased, Malaise, Pain in extremity, Vaccination site pain
Clinical narrative: Case number PHHY2016US107364, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 636460) website on 01 Aug 2016. This report refers to a 52 years old female patient. Past medical history was not reported. Concomitant medications included LEXAPRO (escitalopram oxalate) 10 mg. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) along with Pneumococcal vaccine (manufacturer unknown and batch number: not reported) both in right arm on 19 Oct 2015. On the same day after vaccination, the vaccination site became extremely painful. The patient could not lift arm and had trouble starting her car as the arm hurt. The patient drove the car crying uncontrollably due to pain. Once home, the patient was taken into the emergency room due to extreme pain and ill feeling. Her arm and shoulder did not healed properly. The patient reported that she experience pain daily. The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 31.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2016US105197, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 636461) website on 01 Aug 2016. This report refers to a 31 years old male patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) into left arm on 18 May 2016. On 19 May 2016, the patient experienced pronounced (but on-allergic-appearing) swelling, redness, soreness at injection site. The outcome of events was reported as unknown. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 54.0
Sex: F
Vaccine: FLUX, FLUX, FLUX
Symptoms: Injection site joint pain, Injection site reaction, Joint crepitation
Clinical narrative: Case number PHHY2016US105806, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 637047). This report refers to a 54 year old female patient. Medical history included fibromyalgia. The patient's past medications included amoxicillin and sulfa and influenza (please refers case no. PHHY2016US106059). Concomitant medications included FLEXERIL, lisinopril, HCTZ, MOBIC and loratadine. The patient was vaccinated with influenza virus seasonal vaccine (Manufacturer unknown, batch number: not reported) on 08 Mar 2016 in the left arm. On the same day after vaccination the patient experienced left shoulder joint sore, pain in joint clicks at times and got better some. Final outcome of the events was reported as condition unchanged. Seriousness of the events was reported as non serious. Causality of the events was not reported.
Age: 54.0
Sex: F
Vaccine: FLUX, FLUX, FLUX
Symptoms: Injection site joint pain, Joint crepitation
Clinical narrative: Case number PHHY2016US105806, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 637047). This report refers to a 54 year old female patient. Medical history included fibromyalgia. The patient's past medications included amoxicillin and sulfa and influenza (please refers case no. PHHY2016US106059). Concomitant medications included FLEXERIL, lisinopril, HCTZ, MOBIC and loratadine. The patient was vaccinated with influenza virus seasonal vaccine (Manufacturer unknown, batch number: not reported) on 08 Mar 2016 in the left arm. On the same day after vaccination the patient experienced left shoulder joint sore, pain in joint clicks at times and got better some. Final outcome of the events was reported as condition unchanged. Seriousness of the events was reported as non serious. Causality of the events was not reported.
Age: 54.0
Sex: F
Vaccine: FLUX, FLUX, FLUX
Symptoms: Musculoskeletal pain
Clinical narrative: Case number PHHY2016US105806, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 637047). This report refers to a 54 year old female patient. Medical history included fibromyalgia. The patient's past medications included amoxicillin and sulfa and influenza (please refers case no. PHHY2016US106059). Concomitant medications included FLEXERIL, lisinopril, HCTZ, MOBIC and loratadine. The patient was vaccinated with influenza virus seasonal vaccine (Manufacturer unknown, batch number: not reported) on 08 Mar 2016 in the left arm. On the same day after vaccination the patient experienced left shoulder joint sore, pain in joint clicks at times and got better some. Final outcome of the events was reported as condition unchanged. Seriousness of the events was reported as non serious. Causality of the events was not reported.
Sex: U
Vaccine: FLUX, FLUX, FLUX
Symptoms: Injection site joint pain, Injection site reaction, Joint crepitation
Clinical narrative: Case number PHHY2016US105806, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 637047). This report refers to a 58 year old patient (gender not reported). Medical history and concomitant medications were not reported. The patient was vaccinated with Influenza Virus seasonal vaccine (Manufacturer unknown, batch number: not reported) on an unknown date. After vaccination, the patient experienced sore shoulder. Outcome, seriousness and causality of the event was not reported.
Sex: U
Vaccine: FLUX, FLUX, FLUX
Symptoms: Injection site joint pain, Joint crepitation
Clinical narrative: Case number PHHY2016US105806, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 637047). This report refers to a 58 year old patient (gender not reported). Medical history and concomitant medications were not reported. The patient was vaccinated with Influenza Virus seasonal vaccine (Manufacturer unknown, batch number: not reported) on an unknown date. After vaccination, the patient experienced sore shoulder. Outcome, seriousness and causality of the event was not reported.
Sex: U
Vaccine: FLUX, FLUX, FLUX
Symptoms: Musculoskeletal pain
Clinical narrative: Case number PHHY2016US105806, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 637047). This report refers to a 58 year old patient (gender not reported). Medical history and concomitant medications were not reported. The patient was vaccinated with Influenza Virus seasonal vaccine (Manufacturer unknown, batch number: not reported) on an unknown date. After vaccination, the patient experienced sore shoulder. Outcome, seriousness and causality of the event was not reported.
Sex: F
Vaccine: FLUX, MENB, FLUX, MENB
Symptoms: Rash generalised
Clinical narrative: Case number PHHY2016US105621, is an initial spontaneous report received from Nurse via Pfizer sales representative via Vaccine Adverse Event Reporting System (VAERS reference number: 637418). This report refers to a female patient of an unknown age. Medical history and concomitant medication were not reported. Vaccination history included administration of TRUMENBA (batch number: not reported) on an unknown date. The patient did not experience any reaction post vaccination with TRUMENBA. The patient was vaccinated with seasonal influenza virus vaccine (manufacturer unknown, batch number: not reported) and second dose of TRUMENBA (other manufacturer, batch number: not reported) in the arm on an unknown date. After vaccination, the patient experienced rash all over body. The nurse reported that, rash was not on the arm that the vaccine was given but was all over the body. Outcome the event was reported as unknown. Seriousness of the event was reported as non serious and causality was not reported. Seriousness of the event rash generalized was upgraded based on the available information in the source document.
Sex: F
Vaccine: FLUX, MENB, FLUX, MENB
Symptoms: Musculoskeletal stiffness, Nausea, Pyrexia
Clinical narrative: Case number PHHY2016US107161, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 637431) website on 01 Aug 2016. This report refers to an unknown age of female patient. It was reported that two patients experienced similar events. This is the first of two reports. Past medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. The patient was also vaccinated with single dose of TRUMENBA (other manufacture, batch number: not reported) on an unknown date. On an unspecified date 03 or 04 days after vaccination, the patient experienced fever, body stiffness and nausea. The outcome of events was reported as unknown. The seriousness of the events was reported as non serious. The causality of the events was not reported. Follow up was attempted and no further information was expected.